tert-Butyl 4-(methyl(6-[5-(methylsulfonyl)-2,3-dihydro-1H-indo1l-1-yl]pyrimidin-4-yl)amino)piperidine-1-carboxylate

ID: ALA4871114

PubChem CID: 58116588

Max Phase: Preclinical

Molecular Formula: C24H33N5O4S

Molecular Weight: 487.63

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(c1cc(N2CCc3cc(S(C)(=O)=O)ccc32)ncn1)C1CCN(C(=O)OC(C)(C)C)CC1

Standard InChI:  InChI=1S/C24H33N5O4S/c1-24(2,3)33-23(30)28-11-9-18(10-12-28)27(4)21-15-22(26-16-25-21)29-13-8-17-14-19(34(5,31)32)6-7-20(17)29/h6-7,14-16,18H,8-13H2,1-5H3

Standard InChI Key:  BDWMCRCCWFPXMC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   22.5429   -3.6031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5470   -4.4203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2527   -4.0081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1753   -1.2671    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5880   -1.9769    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.9965   -1.2646    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2965   -2.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2954   -3.2050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7102   -2.3819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0016   -1.9766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7131   -3.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0024   -3.6127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1709   -4.4148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9858   -4.5024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3208   -3.7544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1205   -3.5863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6623   -4.1943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4614   -4.0267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7164   -3.2494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1662   -2.6395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3692   -2.8102    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0065   -4.6355    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8063   -4.4679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3498   -5.0822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1466   -4.9171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4053   -4.1416    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8610   -3.5308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0580   -3.6955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2058   -3.9770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7486   -4.5878    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.4634   -3.2015    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8811   -2.3858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0918   -5.0340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7518   -5.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  2  0
  6  5  2  0
  7  8  2  0
  8 12  1  0
 11  9  1  0
  9 10  2  0
 10  7  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 18 22  1  0
 22 23  1  0
 23 24  1  0
 23 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 26 29  1  0
 29 30  1  0
 29 31  2  0
  7  5  1  0
  5 32  1  0
 30  2  1  0
  2 33  1  0
 22 34  1  0
M  END

Associated Targets(Human)

GPR119 Tclin Glucose-dependent insulinotropic receptor (4762 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 487.63Molecular Weight (Monoisotopic): 487.2253AlogP: 3.41#Rotatable Bonds: 4
Polar Surface Area: 95.94Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.83CX LogP: 2.82CX LogD: 2.81
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.65Np Likeness Score: -1.63

References

1. Kubo O, Takami K, Kamaura M, Watanabe K, Miyashita H, Abe S, Matsuda K, Tsujihata Y, Odani T, Iwasaki S, Kitazaki T, Murata T, Sato K..  (2021)  Discovery of a novel series of GPR119 agonists: Design, synthesis, and biological evaluation of N-(Piperidin-4-yl)-N-(trifluoromethyl)pyrimidin-4-amine derivatives.,  41  [PMID:34010766] [10.1016/j.bmc.2021.116208]

Source